Facial plastic surgeon Steven Mobley recently pinned the ears of a 6-year-old Utah boy who was subjected to intense bullying, according to his parents. The boy's father said his son is "much more confident" since the surgery.
Anvisa, the Brazilian health regulatory agency, has suspended the production and sale of silicone breast and other implants by the firm Silimed after an inspection by a German entity found manufacturing surfaces were contaminated with particles. Silimed, the largest maker of silicone implants in South America, said the particles do not pose a health risk. Australia and Switzerland joined the European Union in asking surgeons not to use implants made by the company until investigations have been completed.
The CMS issued a request for information, asking physicians to weigh in on whether Medicare reimbursement should be linked partly to accepting new Medicaid patients or to participating in health plans offered through Affordable Care Act exchanges. The CMS is developing a Merit-Based Incentive Payment System to replace the sustainable growth rate formula.
The ICD-10 transition largely went well last week due to hard work spent preparing for the new codes, but claims rejections could still cause problems, said hospital executives, IT experts and health care consultants. "The real test will be claims flow as we near the end of the month," CHIME President and CEO Russ Branzell said. CMS Deputy Administrator Sean Cavanaugh said the agency won't immediately know how the transition is going, but he said the CMS had exhaustively tested its claims processing and would be able to accept properly coded claims.
Facial plastic and reconstructive surgeon Jeffrey Spiegel brought attendees at the annual American Academy of Facial Plastic and Reconstructive Surgery Conference up to speed on transgender issues and facial feminization procedures. "We don't get to pick what a woman looks like," Spiegel said. "... We're trying to understand what it is, not define what it is."
Techshot is developing technology for producing large blood vessels using salmon fibrinogen and adipose-derived human stem cells. The project has been granted $1.15 million from the Pentagon's Defense Health Program, and the company is planning to initiate preclinical studies this year.